Insider trade

Roivant Sciences (ROIV): Director sold ~$6.78M

Mayukh Sukhatme, Director at Roivant Sciences, sold ~$6.78M of Roivant Sciences shares.

~$6.78M
Approx. value · 312K sh @ $21.74
19.3M
Holds after · shares reported
Traded
Dec 29, 2025
Filed
Jan 1, 2026

What stands out in this filing

  • The sale was 1.6% of the shares this insider held before it; the filing reports 19,273,032 shares afterwards.
  • 311,873 shares at an average of $21.74 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  2. Oct 31, 2025CongressDisclosed sale of ROIV — reported range $1,001 - $15,000
  3. Nov 7, 2025InsiderCEO sold ~$4.04M of ROIV shares in the open market
  4. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
  5. Nov 13, 2025Insider10% owner sold ~$5.98M of ROIV shares in the open market
  6. Nov 14, 2025Insider10% owner sold ~$20.9M of ROIV shares in the open market
  7. Nov 17, 2025Insider10% owner sold ~$11.1M of ROIV shares in the open market
  8. Nov 19, 2025Insider · 3 peopleInsiders: 12 sales (~$78.9M)
  9. Dec 9, 2025InsiderCEO sold ~$4.17M of ROIV shares in the open market
  10. Dec 11, 2025Insider10% owner sold ~$16.8M of ROIV shares in the open market
  11. Dec 12, 2025Insider · Their largest sale since 202310% owner sold ~$43.4M of ROIV shares in the open market
  12. Dec 15, 2025Insider · 2 peopleInsiders: 4 sales (~$45.5M)
  13. Dec 16, 2025Insider · 3 peopleInsiders: 6 sales (~$63.4M)
  14. Dec 17, 2025Insider · 4 peopleInsiders: 10 sales (~$54.4M)
  15. Dec 23, 2025Insider · 2 peopleInsiders: 3 sales (~$13.6M)
  16. Dec 24, 2025InsiderCEO sold ~$1.69M of ROIV shares in the open market
  17. Dec 29, 2025 · this disclosureInsiderDirector sold ~$6.78M of ROIV shares in the open market

What came next

  1. Dec 31, 2025Insider · Their largest sale since 2024Director sold ~$22.1M of ROIV shares in the open market
  2. Jan 12, 2026InsiderCEO sold ~$4.38M of ROIV shares in the open market
  3. Feb 6, 2026Company filing · Form 8-K · ResultsReported its results
  4. Feb 9, 2026InsiderDirector sold ~$8.99M of ROIV shares in the open market
  5. Feb 11, 2026Insider · 3 peopleInsiders: 3 sales (~$34.0M)
  6. Feb 12, 2026Insider · 3 peopleInsiders: 6 sales (~$34.1M)
  7. Feb 13, 2026Insider · 4 peopleInsiders: 7 sales (~$35.2M)
  8. Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
  9. Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
  10. Feb 23, 2026InsiderChair sold ~$16.2M of ROIV shares in the open market
  11. Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  12. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  13. Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
  14. Mar 17, 2026InsiderCEO sold ~$5.65M of ROIV shares in the open market
  15. Mar 26, 2026Insider · 7 days before resultsDirector sold ~$1.92M of ROIV shares in the open market
  16. Apr 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  17. Apr 8, 2026InsiderOfficer sold ~$384K of ROIV shares in the open market
  18. Apr 16, 2026InsiderCEO sold ~$8.45M of ROIV shares in the open market
  19. Apr 20, 2026InsiderCEO sold ~$5.92M of ROIV shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Mayukh Sukhatme, President & CIO

The full history of Mayukh Sukhatme, President & CIO is on the profile page.

How this filing works

Explore the data

Common questions

Which Roivant Sciences (ROIV) insider traded, and how much?

Mayukh Sukhatme, Director at Roivant Sciences, sold ~$6.78M of Roivant Sciences shares. 312K shares at $21.74.

When did it happen, and when was it made public?

Traded: Dec 29, 2025. Filed: Jan 1, 2026. That is 3 days between the two dates.

What stands out in this filing?

The sale was 1.6% of the shares this insider held before it; the filing reports 19,273,032 shares afterwards. 311,873 shares at an average of $21.74 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Roivant Sciences recently?

For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ROIV page.

Does this mean ROIV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data